Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Keiichi Mashimo"'
Publikováno v:
Nihon Toseki Igakkai Zasshi. 44:427-433
危険な有毒ガスとして知られる硫化水素がヒト体内でもシステインからcystathionine β-synthase（CBS）やcystathionine γlyase（CSE）により産生されることが知られている．この物質は神経伝達物質
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0c837b56eb13b104bb4d6975577b122
https://doi.org/10.4009/jsdt.44.427
https://doi.org/10.4009/jsdt.44.427
Autor:
Toshihiko Ono, Hiroyuki Kobayashi, Yuzo Kimura, Kentaro Mera, Takashi Sato, Hirohisa Kawahara, Shu Kawashima, Noritomo Itami, Shigefumi Koike, Yasushi Nakamoto, Ryoichi Miyazaki, Takashi Mizuguchi, Yoshiharu Haga, Yasushi Saika, Kazuhi Taniai, Yoshihei Hirasawa, Seiji Ohira, Kazumichi Ohta, Norio Kurosawa, Kougi Yuu, Koji Usui, Hironobu Kawai, Hisashi Takahashi, Hachiro Seno, Ryuji Miki, Senji Okuno, Yukitaka Maruyama, Keiichi Mashimo, Masashi Suzuki, Masao Kim, Ken-ichi Fukunari, Mitsuyoshi Furuhashi, Yoshihiro Motomiya, Kenichiro Shigemoto, Kazuo Numazawa, Isahiro Obara, Tsuguo Mizuno, Kenji Yuasa
Publikováno v:
Nihon Toseki Igakkai Zasshi. 36:1265-1272
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf34a8b9ffe88617e2c9783b4e8187c1
https://doi.org/10.4009/jsdt.36.1265
https://doi.org/10.4009/jsdt.36.1265
Autor:
Shintarou Yano, Shintaro Higuchi, Noriyuki Hiramatsu, Keiichi Mashimo, Ryoji Yoshida, Hidetoshi Yamanaka, Yukiko Abe, Masamichi Hayashi, Shigeo Tamura, Yasuhiro Okubo, Hironobu Kawai, Kazuto Inose, Takuji Naruse, Kurokawa K
Publikováno v:
Nihon Toseki Igakkai Zasshi. 32:1149-1153
我々は末期腎不全にて発見された, 非癒合性交叉性骨盤腎の1例を経験した. 症例は36歳男性で, 昭和61年頃から腹満感, 平成6年頃から膝関節痛および夜間頻尿を自覚し, また平成7年4月頃に
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e91e61e7bb2d15c1a165a5494a5cacca
https://doi.org/10.4009/jsdt.32.1149
https://doi.org/10.4009/jsdt.32.1149
Autor:
Ryoji Wakamatsu, Kazue Ueki, Miyuki Naitoh, Hironobu Kawai, Yoshito Tsukada, Akiyasu Tsuchida, Yoshihisa Nojima, Keiichi Mashimo, Shigeo Tamura, Yukiko Abe
Publikováno v:
Clinical and experimental nephrology. 9(3)
1,25-dihydroxy-22-ovavitamin D(3) (22-oxacalcitriol, OCT) was recently introduced commercially as an analogue of 1,25 (OH)(2) vitamin D(3), but one which has less pronounced calcemic activity.To examine the efficacy and tolerability of OCT, 46 hemodi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea118c98aebbf1c957dbc63d6f1c670
https://pubmed.ncbi.nlm.nih.gov/16189633
https://pubmed.ncbi.nlm.nih.gov/16189633